As part of our Biosimilars Advisory Service, Decision Resources is offering an exclusive webinar entitled How Will News of Teva’s Early Stage Trials of Biosimilar Rituximab Alter Expectations for Complex Biosimilars? This webinar is open ONLY to subscribers of Decision Resources’ new Biosimilars Advisory Service.
This webinar was held on June 23, 2010. Contact us to learn how you can purchase this service and access a recorded playback of this event.
Click here to view the invite.